177 related articles for article (PubMed ID: 36479812)
1. Study on combination therapy for lung cancer through pemetrexed-loaded mesoporous polydopamine nanoparticles.
Xu J; Xu W; Wang Z; Jiang Y
J Biomed Mater Res A; 2023 Feb; 111(2):158-169. PubMed ID: 36479812
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.
Zhang L; Yang P; Guo R; Sun J; Xie R; Yang W
Int J Nanomedicine; 2019; 14():8647-8663. PubMed ID: 31806962
[TBL] [Abstract][Full Text] [Related]
3. Metal-polyphenol polymer modified polydopamine for chemo-photothermal therapy.
Xu L; Luo Z; Liu Q; Wang C; Zhou F; Zhou M
Front Chem; 2023; 11():1124448. PubMed ID: 36762199
[TBL] [Abstract][Full Text] [Related]
4. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe
Shu G; Chen M; Song J; Xu X; Lu C; Du Y; Xu M; Zhao Z; Zhu M; Fan K; Fan X; Fang S; Tang B; Dai Y; Du Y; Ji J
Bioact Mater; 2021 May; 6(5):1423-1435. PubMed ID: 33210034
[TBL] [Abstract][Full Text] [Related]
5. Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation.
Huang X; Chen L; Lin Y; Tou KI; Cai H; Jin H; Lin W; Zhang J; Cai J; Zhou H; Pi J
Acta Biomater; 2021 Dec; 136():456-472. PubMed ID: 34562660
[TBL] [Abstract][Full Text] [Related]
6. pH-Responsive Sorafenib/Iron-Co-Loaded Mesoporous Polydopamine Nanoparticles for Synergistic Ferroptosis and Photothermal Therapy.
Liu S; Liu Y; Chang Q; Celia C; Deng X; Xie Y
Biomacromolecules; 2024 Jan; 25(1):522-531. PubMed ID: 38087829
[TBL] [Abstract][Full Text] [Related]
7. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals.
Li R; Hu X; Shang F; Wu W; Zhang H; Wang Y; Pan J; Shi S; Dong C
Acta Biomater; 2022 Aug; 148():218-229. PubMed ID: 35705171
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer.
Dai L; Wei D; Zhang J; Shen T; Zhao Y; Liang J; Ma W; Zhang L; Liu Q; Zheng Y
Cell Prolif; 2021 Nov; 54(11):e13130. PubMed ID: 34599546
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous Polydopamine-Based Nanovehicles as a Versatile Drug Loading Platform to Enable Tumor-Sufficient Synergistic Therapy.
Jiang S; Zhu F; Ji X; Li J; Tian H; Wang B; Lu L; Wang P
ChemMedChem; 2022 Oct; 17(19):e202200360. PubMed ID: 36000799
[TBL] [Abstract][Full Text] [Related]
10. In vitro Antitumor Properties of Fucoidan-Coated, Doxorubicin-Loaded, Mesoporous Polydopamine Nanoparticles.
Xu H; Ling J; Zhao H; Xu X; Ouyang XK; Song X
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500550
[TBL] [Abstract][Full Text] [Related]
11. Near-Infrared Light-Activated Mesoporous Polydopamine for Temporomandibular Joint Osteoarthritis Combined Photothermal-Chemo Therapy.
Li Q; Hou Y; Cao P; Bi R; Zhu S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240401
[TBL] [Abstract][Full Text] [Related]
12. A multifunctional nanocomposite coated with a BSA membrane for cascaded nitric oxide therapy.
Ren R; Bremner DH; Chen W; Shi A; Wang T; Wang Y; Wang C; Wu J; Zhu LM
Int J Biol Macromol; 2023 May; 238():124087. PubMed ID: 36940766
[TBL] [Abstract][Full Text] [Related]
13. Oxygen-supplementing mesoporous polydopamine nanosponges with WS
Wang Y; Song S; Lu T; Cheng Y; Song Y; Wang S; Tan F; Li J; Li N
Biomaterials; 2019 Nov; 220():119405. PubMed ID: 31408811
[TBL] [Abstract][Full Text] [Related]
14. NIR-/pH-Responsive Nanocarriers Based on Mesoporous Hollow Polydopamine for Codelivery of Hydrophilic/Hydrophobic Drugs and Photothermal Synergetic Therapy.
Li S; Gan Y; Lin C; Lin K; Hu P; Liu L; Yu S; Zhao S; Shi J
ACS Appl Bio Mater; 2021 Feb; 4(2):1605-1615. PubMed ID: 35014509
[TBL] [Abstract][Full Text] [Related]
15. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
[TBL] [Abstract][Full Text] [Related]
16. Ultrasmall Gold-Coated Mesoporous Polydopamine Nanoprobe to Enhance Chemodynamic Therapy by Self-Supplying H
Wang Z; Shi Y; Shi Y; Zhang J; Hao R; Zhang G; Zeng L
ACS Appl Mater Interfaces; 2022 Dec; 14(49):54478-54487. PubMed ID: 36448730
[TBL] [Abstract][Full Text] [Related]
17. Delivery of Doxorubicin by Ferric Ion-Modified Mesoporous Polydopamine Nanoparticles and Anticancer Activity against HCT-116 Cells In Vitro.
Guo M; Ling J; Xu X; Ouyang X
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047825
[TBL] [Abstract][Full Text] [Related]
18. Near-Infrared Light-Triggered Nitric-Oxide-Enhanced Photodynamic Therapy and Low-Temperature Photothermal Therapy for Biofilm Elimination.
Yuan Z; Lin C; He Y; Tao B; Chen M; Zhang J; Liu P; Cai K
ACS Nano; 2020 Mar; 14(3):3546-3562. PubMed ID: 32069025
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous polydopamine-based nanoplatform for enhanced tumor chemodynamic therapy through the reducibility weakening strategy.
Zhang Q; Xu X; Yang Q; Duan Y; Chen C; Zhao S; Ouyang Y; Chen Y; Cao Y; Liu H
Colloids Surf B Biointerfaces; 2023 Feb; 222():113091. PubMed ID: 36542951
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous polydopamine nanoparticles with co-delivery function for overcoming multidrug resistance via synergistic chemo-photothermal therapy.
Xing Y; Zhang J; Chen F; Liu J; Cai K
Nanoscale; 2017 Jun; 9(25):8781-8790. PubMed ID: 28621774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
